New federal legislation that would make it easier for all cancer patients to participate in clinical trials was introduced today in the House of Representatives. Sponsored by U.S. Reps. Raul Ruiz (D-Calif.) and August Pfluger (R-Texas), the Clinical Trial Modernization Act would help remove cost and geographic hurdles that prevent patients from participating in clinical trials.
Today, the president released his proposed budget for Fiscal Year 2026 which contains a 26.2% cut to the Department of Health and Human Services (HHS). This includes a 37% cut to the National Institutes of Health (NIH) and eliminates the National Center for Chronic Disease Prevention and Health Promotion at the Centers for Disease Control and Prevention (CDC).
With Friday marking the end of the legislative session in Hawai’i, cancer survivors, patients, and advocates with the American Cancer Society Cancer Action Network (ACS CAN) commend the state legislature for committing to health equity by passing a bill that enables researchers to study why cancer disproportionately impacts Native Hawaiians, Pacific Islanders, and Asian Americans including Filipinos in Hawai’i.
Maryland state lawmakers have released details on the agreed upon 2025-26 budget—the contents of which are a mixed bag in the fight against cancer. While the state made sound investments in cancer research and protected Medicaid recipients’ ability to access biomarker testing, it missed an opportunity to save the lives and lungs of Maryland’s youth by cutting funding for the state’s tobacco prevention and cessation programs.
Yesterday, the U.S. Senate voted to confirm Jay Bhattacharya, MD, PhD, as the new director of the National Institutes of Health (NIH).
Today, the U.S. House passed The Full-Year Continuing Appropriations and Extensions Act, 2025. It contains no increases for federal cancer research or prevention funding and significant cuts to Congressionally Directed Medical Research Programs (CDMRP), in which cancer is the largest recipient of funds.
“With over 2 million people in America expected to be diagnosed with cancer in 2025, now is not the time to halt investments in cancer research, prevention and early detection programs.
WASHINGTON, DC— 3 de enero de 2025 — “Mientras se reúne hoy el 119.º Congreso, ACS CAN insta a los miembros a mantener a los pacientes y sobrevivientes de cáncer en el centro de cada decisión de políticas de salud, desde el financiamiento de la investigación del cáncer hasta la g
MILWAUKEE, Wis. – Deb Nevels was awarded (ACT!) Lead of the Year by the American Cancer Society Cancer Action Network (ACS CAN) for her exceptional commitment to advocacy work and making cancer a national priority.
Sobrevivientes de cáncer, pacientes y cuidadores se reunieron el martes por la noche en Phoenix para honrar a los habitantes de Arizona afectados por la enfermedad. El evento, que se llevó a cabo en el Instituto Oncológico Dignity Health en St. Joseph’s, fue organizado por la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) como parte de Luces de Esperanza por Todo el País (Lights of Hope Across America), el evento distintivo de recaudación de fondos de la organización destinada a fortalecer la misión de reducir el sufrimiento del cáncer para todas las personas.